|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Epidemiology and Outcomes |
,







* Department of Pediatrics, Johns Hopkins Childrens Center, Baltimore,
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, and
The Welch Center for Prevention, Epidemiology & Clinical Research, Baltimore, Maryland;
National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland; || Montefiore Medical Center, Bronx, New York; ¶ Oregon Health & Science University, Portland, Oregon; ** University of Rochester, Rochester, New York; 
University of New Mexico, Albuquerque, New Mexico; and 
Childrens Mercy Hospital, Kansas City, Missouri
Address correspondence to: Dr. Susan L. Furth, The Johns Hopkins Medical Institutions, Departments of Pediatrics and Epidemiology, The Welch Center for Prevention, Epidemiology & Clinical Research, 2024 E. Monument Street, Baltimore MD, 21287. Phone: 410-502-7964; Fax: 410-614-3680; E-mail: sfurth{at}jhmi.edu
An estimated 650,000 Americans will have ESRD by 2010. Young adults with kidney failure often develop progressive chronic kidney disease (CKD) in childhood and adolescence. The Chronic Kidney Disease in Children (CKiD) prospective cohort study of 540 children aged 1 to 16 yr and have estimated GFR between 30 and 75 ml/min per 1.73 m2 was established to identify novel risk factors for CKD progression; the impact of kidney function decline on growth, cognition, and behavior; and the evolution of cardiovascular disease risk factors. Annually, a physical examination documenting height, weight, Tanner stage, and standardized BP is conducted, and cognitive function, quality of life, nutritional, and behavioral questionnaires are completed by the parent or the child. Samples of serum, plasma, urine, hair, and fingernail clippings are stored in biosamples and genetics repositories. GFR is measured annually for 2 yr, then every other year using iohexol, HPLC creatinine, and cystatin C. Using age, gender, and serial measurements of Tanner stage, height, and creatinine, compared with iohexol GFR, a formula to estimate GFR that will improve on traditional pediatric GFR estimating equations when applied longitudinally is expected to be developed. Every other year, echocardiography and ambulatory BP monitoring will assess risk for cardiovascular disease. The primary outcome is the rate of decline of GFR. The CKiD study will be the largest North American multicenter study of pediatric CKD.
This article has been cited by other articles:
![]() |
C. M. Soares, J. S. S. Diniz, E. M. Lima, G. R. Oliveira, M. R. Canhestro, E. A. Colosimo, A. C. Simoes e Silva, and E. A. Oliveira Predictive factors of progression to chronic kidney disease stage 5 in a predialysis interdisciplinary programme Nephrol. Dial. Transplant., October 13, 2008; (2008) gfn547v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Flynn, M. Mitsnefes, C. Pierce, S. R. Cole, R. S. Parekh, S. L. Furth, B. A. Warady, and for the Chronic Kidney Disease in Children Study G Blood Pressure in Children With Chronic Kidney Disease: A Report From the Chronic Kidney Disease in Children Study Hypertension, October 1, 2008; 52(4): 631 - 637. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Peralta and M. G. Shlipak Hypertension in Children With Chronic Kidney Disease: A Call to Action Hypertension, October 1, 2008; 52(4): 610 - 612. [Full Text] [PDF] |
||||
![]() |
J. J. Fadrowski, C. B. Pierce, S. R. Cole, M. Moxey-Mims, B. A. Warady, and S. L. Furth Hemoglobin Decline in Children with Chronic Kidney Disease: Baseline Results from the Chronic Kidney Disease in Children Prospective Cohort Study Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 457 - 462. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |